Abstract
Objective: This research was conducted to find potential candidate compounds from one hundred thirty-seven Indonesian marine natural products capable of preventing SARS-CoV-2 with a computational approach.
Methods: The physicochemical properties and Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) profile of compounds were predicted using ADMETLab. The candidate compounds were filtered using AutodockVina. Molecular docking was carried out using AutoDockTools on the SARS-CoV-2 3-Chymotrypsin-like protease (3CLpro) and Papain-like protease (PLpro) that is essential for the SARS-CoV-2 life cycle. Also, AMBER22 was used to perform molecular dynamics simulations in this study.
Results: Based on molecular docking results, Pre-Neo-Kaluamine has good activity against 3CLpro with a bond energy value of-10.35 kcal/mol. Cortistatin F showed excellent binding activity on PLpro, with energy value results of-10.62 kcal/mol. Acanthomanzamine C has dual targeting activity and interacts well with protein 3CLpro and PLpro with binding energy values ranging from 10 kcal/mol to 14 kcal/mol.
Conclusion: The molecular docking results were corroborated by molecular dynamics simulation results and showed good stability of the candidate ligands, and we found that there were three potential compounds as protease inhibitors of SARS-CoV-2 including Pre-Neo-Kaluamine for 3CLpro, Cortistatin F for PLpro, and Acanthomanzamine C which had dual targeting activity against both proteases.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference45 articles.
1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-13. doi: 10.1016/S0140-6736(20)30211-7, PMID 32007143.
2. Sukumaran S, Sathianarayanan S. A review on covid-19 pandemic a global threat-current status and challenges and preventive strategies. Int J Appl Pharm. 2021 Sep 7:10-4.
3. Mohammad Zadeh N, Mashinchi Asl NS, Forouharnejad K, Ghadimi K, Parsa S, Mohammadi S. Mechanism and adverse effects of Covid-19 drugs: a basic review. Int J Physiol Pathophysiol Pharmacol. 2021;13(4):102-9. PMID 34540130.
4. Jain NK, Agrawal A, Kulkarni GT, Tailang M. Molecular docking study on phytoconstituents of traditional ayurvedic drug TULSI (ocimum sanctum linn.) against covid-19 MPRO enzyme: an in silico study. Int J Pharm Pharm Sci. 2022 Apr 1:44-50. doi: 10.22159/ijpps.2022v14i4.43181.
5. Rajpoot S, Alagumuthu M, Baig MS. Dual targeting of 3CLpro and PLpro of SARS-CoV-2: a novel structure-based design approach to treat covid-19. Curr Res Struct Biol. 2021 Jan 1;3:9-18. doi: 10.1016/j.crstbi.2020.12.001, PMID 33319212.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献